CHOLUDEXAN

Articles

• Choludexan and viral hepatitis: what is common? Published in the journal «District Doctor» October-November’2017
• Pathogenetic treatment of patients with chronic viral hepatitis with severe liver fibrosis: aspects of UDCA application
• Primary biliary cholangitis: innovation and consistency in the EASL guidelines Published in a journalе «District doctor» May-June’2017
• UDCA and “large” cholestatic liver diseases Published in the journal «District Doctor» april’2017
• «Dissolution» of gall stones: dreams or reality? Published in a journal «District doctor» мarch’2017
• Pathogenetic reasons for use of hepatoprotector with approval clinical efficancy – ursodeoxycholic ACID: from discovery history to evidence base Published in a journal «District doctor» february’2017
• Metabolic syndrome: state of the problem and approaches to therapy Published in the journal «Modern gastroenterology» № 2 (94)’2017
• Gallbladder dysfunction and biliary sludge: clinical implications and current treatment approaches Published in the journal «Modern gastroenterology» № 5 (61)’2011
• Study of the spectrum of bile acids in patients with non-alcoholic fatty liver disease in combination with hyperuricemia Published in the journal «Practitioner» № 4’2014
• Cholestasis in pregnant women: problem or condition? Published in the journal «District Doctor» № 7’2014
• Hepatotoxicity in rheumatological patients: features of the course, possibilities of correction
• Treatment of gallbladder cholesterosis in patients with type 2 diabetes mellitus using ursodeoxycholic acid Published in the journal «Problems of Endocrine Pathology» № 4’2012
• Experience of Choludexan use in the treatment of biliary disfunction in children Published in the journal «Child Health» № 6 (41)’2012
• Biliary sludge and gallstone disease: actual scientific and practical aspects Published in the thematic issue «Gastroenterology. Hepatology. Coloproctology» № 3 (49)’2018
• The effect of bile acid preparations on lipid metabolism in patients with postcholecystectomy syndrome Published in the journal «Modern gastroenterology» № 2 (88)’2016
• Consequences of cholecystectomy and principles of their correction and prevention Published in the thematic issue «Gastroenterology. Hepatology. Coloproctologists» № 2 (52)’2019
• Rationale for the use of ursodeoxycholic acid in the treatment of non-alcoholic steatohepatitis Published in the journal «Bulletin of the club of pancreatologists» Vol 42 № 1’2019
• Drug – induced liver injury: from pathogenesis to treatment Published in the journal «Bulletin of the club of pancreatologists» Vol 46 № 1’2020
• Biliary dyskinesias: traditional and modern views Published in the journal «Bulletin of the club of pancreatologists» Vol 45 № 4’2019
• Dynamics of lipid spectrum indices, endothelial function, and insulin resistance in patients with coronary heart disease in combination with non-alcoholic steatosis Published in the journal «Zaporozhye Medical Journal» Vol 21 № 3 (114)’2019
• Hepatological risk in the treatment of overweight and obesity: possible ways of prevention Published in the journal «Health of Ukraine» № 4 (281)’2012
• Prognosismodifying therapy in patients with CAD: how to optimize treatment? Published in medical gazette «Health of Ukraine 21st century» № 20 (441)’2018
• Drug-induced liver lesions: modern approaches to treatment Published in the journal «Bulletin of the Club of Pancreatologists» № 8’2018
• The role of ursodeoxycholic acid preparations in treatment regimens of hepatobiliary-pancreatic diseases associated with metabolic syndrome Published in the journal «Bulletin of the Club of Pancreatologists» Vol 55 № 2’2022